Spyre Therapeutics Files Q1 2025 10-Q
Ticker: SYRE · Form: 10-Q · Filed: May 8, 2025 · CIK: 1636282
| Field | Detail |
|---|---|
| Company | Spyre Therapeutics, Inc. (SYRE) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financials
TL;DR
Spyre Therapeutics filed its Q1 2025 10-Q. All systems go.
AI Summary
Spyre Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Aeglea BioTherapeutics, Inc. until March 11, 2015, is based in Waltham, MA. The filing details financial information and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Spyre Therapeutics, Inc. as of March 31, 2025.
Risk Assessment
Risk Level: medium — As a biotechnology company, Spyre Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of 2025)
- 1231 — Fiscal Year End (Company's fiscal year ends on December 31st)
Key Players & Entities
- Spyre Therapeutics, Inc. (company) — Filer of the 10-Q
- Aeglea BioTherapeutics, Inc. (company) — Former name of Spyre Therapeutics, Inc.
- March 31, 2025 (date) — End of the reporting period
- Waltham, MA (location) — Company's business address
- 20250508 (date) — Filing date
FAQ
What is the primary business of Spyre Therapeutics, Inc.?
Spyre Therapeutics, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the company formerly known as Aeglea BioTherapeutics, Inc.?
The company changed its name from Aeglea BioTherapeutics, Inc. on March 11, 2015.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 8, 2025.
What is the business address of Spyre Therapeutics, Inc.?
The business address is 221 Crescent Street, Building 23, Suite 105, Waltham, MA 02453.
What is the SEC file number for Spyre Therapeutics, Inc.?
The SEC file number is 001-37722.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Spyre Therapeutics, Inc. (SYRE).